百令胶囊联合常规西药治疗慢性肾脏病疗效观察及安全性研究
DOI:
作者:
作者单位:

作者简介:

通讯作者:

中图分类号:

R692

基金项目:


Clinical Observation of Bailing Capsules Combined with Routine Western Medicine for Chronic Kidney Disease and Study on Its Safety
Author:
Affiliation:

Fund Project:

  • 摘要
  • |
  • 图/表
  • |
  • 访问统计
  • |
  • 参考文献
  • |
  • 相似文献
  • |
  • 引证文献
  • |
  • 资源附件
  • |
  • 文章评论
    摘要:

    目的:观察百令胶囊联合常规西药治疗慢性肾脏病的临床疗效及其用药安全性。方法:选取75 例慢性肾脏病患者,根据随机数字表法分为研究组38 例和对照组37 例。对照组给予常规西药治疗,包括降压、降糖、降脂、抗感染、纠正贫血以及维持酸碱平衡等,研究组在对照组的基础上加用百令胶囊口服。2 组均连续治疗3 个月,治疗结束后判定2 组临床疗效及用药安全性,分别检测治疗前后2 组血肌酐(SCr)、血尿素氮(BUN)、甘油三酯(TG)、总胆固醇(TC) 水平;治疗期间监测患者血压、脉搏、心电图、血尿便常规,观察记录用药不良反应。结果:治疗后,研究组临床疗效优于对照组,经秩和检验,差异有统计学意义(P<0.05)。治疗前,2 组中医证候积分比较,差异无统计学意义(P>0.05);治疗后,2 组中医证候积分均较治疗前降低(P<0.05),且研究组中医证候积分低于对照组(P<0.05)。治疗前,2 组SCr、BUN 水平比较,差异无统计学意义(P>0.05);治疗后,2 组SCr、BUN 水平均较治疗前降低(P<0.05),且研究组SCr、BUN 水平低于对照组(P<0.05)。治疗前,2 组TG、TC 水平比较,差异无统计学意义(P>0.05);治疗后,2 组TG、TC 水平均较治疗前降低(P<0.05),且研究组TG、TC 水平低于对照组(P<0.05)。治疗期间,2 组患者血压、脉搏、心电图、血尿便常规均未出现明显异常,且均未出现其他不良反应。结论:百令胶囊联合常规西药治疗慢性肾脏病临床疗效较好,可有效缓解患者临床症状,改善肾功能,降低血脂含量,且无明显不良反应。

    Abstract:

    Abstract: Objective: To observe the clinical effect of Bailing capsules combined with routine western medicine for patients with chronic kidney disease and its medication safety. Methods:A total of 75 cases of patients with chronic kidney disease were selected and divided into the study group and the control group according to the random number table method, 38 and 37 cases in each group respectively. The control group was treated with routine western medicine, including hypotensive drugs, hypoglycemic agents, lipid- lowering drugs, anti- infective agents, anemia correction and acid- base balance,and the study group was additionally given the oral administration of Bailing capsules based on the treatment of the control group. Both groups were treated for three months. After the treatment,the clinical effect and medication safety in the two groups were determined. Before and after treatment,the changes in the contents of serum creatinine(SCr),blood urea nitrogen(BUN),triglyceride(TG) and total cholesterol(TC) in the two groups were detected. During treatment,the incidences of abnormalities in blood pressure, pulse, electrocardiogram, blood routine, urine routine and stool routine were monitored;adverse reactions of medication were observed and recorded. Results:After treatment,the clinical effect in the study group was better than that in the control group,the difference being significant(P<0.05). Before treatment,there was no significant difference being found in the comparison of Chinese medicine syndrome scores between the two groups(P> 0.05). After treatment,Chinese medicine syndrome scores in the two groups were decreased when compared with those before treatment(P<0.05), and the score in the study group was lower than that in the control group(P<0.05). Before treatment,there was no significant difference being found in the comparison of the levels of SCr and BUN between the two groups(P>0.05). After treatment,the levels of SCr and BUN in the two groups were decreased when compared with those before treatment(P<0.05),and the levels of SCr and BUN in the study group were lower than those in the control group(P< 0.05). Before treatment, there was no significant difference being found in the comparison of the levels of TG and TC between the two groups(P>0.05). After treatment, the levels of TG and TC in the two groups were decreased when compared with those before treatment(P<0.05),and the levels in the study group were lower than those in the control group (P<0.05). During treatment,there was no obvious abnormality in blood pressure,pulse,electrocardiogram,blood routine, urine routine and stool routine in the two groups;no obvious adverse reactions occurred either. Conclusion:The therapy of Bailing capsules combined with routine western medicine has a good clinical effect in treating chronic kidney disease,which can effectively relieve clinical symptoms,improve kidney function and reduce the contents of blood lipid,without obvious adverse reactions.

    参考文献
    相似文献
    引证文献
引用本文

贾倩倩,丁国印,王东海.百令胶囊联合常规西药治疗慢性肾脏病疗效观察及安全性研究[J].新中医,2021,53(20):62-65

复制
分享
文章指标
  • 点击次数:
  • 下载次数:
  • HTML阅读次数:
  • 引用次数:
历史
  • 收稿日期:
  • 最后修改日期:
  • 录用日期:
  • 在线发布日期: 2021-10-22
  • 出版日期: